Concierge Medicine Today

Personalized cancer therapies show great promise. The hitch? Manufacturing them efficiently | STAT

By Meghana Keshavan

June 9, 2017- It’s been a good month for companies developing the experimental immunotherapies known as CAR-T, as several released data showing strong results in patients with blood cancers.  Now, though, they face a new challenge: Proving they can actually manufacture the highly personalized treatments quickly and efficiently — and get them to cancer patients across the country. 



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: